Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)
HKD 11.62
(1.93%)
HKD 11.62
(1.93%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 340.91 Million CNY | 39.9% |
| 2022 | 243.67 Million CNY | -52.36% |
| 2021 | 511.45 Million CNY | 13.73% |
| 2020 | 449.69 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 171.86 Million CNY | -1.17% |
| 2024 Q2 | 171.86 Million CNY | 0.0% |
| 2023 Q4 | 340.91 Million CNY | 0.0% |
| 2023 FY | 340.91 Million CNY | 39.9% |
| 2023 Q3 | 340.9 Million CNY | 42.47% |
| 2023 Q2 | 239.28 Million CNY | 0.0% |
| 2023 Q1 | 239.28 Million CNY | -1.8% |
| 2022 Q1 | 527.64 Million CNY | 3.17% |
| 2022 FY | 243.67 Million CNY | -52.36% |
| 2022 Q4 | 243.67 Million CNY | 0.0% |
| 2022 Q3 | 243.67 Million CNY | -54.82% |
| 2022 Q2 | 539.34 Million CNY | 2.22% |
| 2021 Q3 | 62.9 Million CNY | 0.0% |
| 2021 Q1 | - CNY | 0.0% |
| 2021 FY | 511.45 Million CNY | 13.73% |
| 2021 Q4 | 511.45 Million CNY | 713.1% |
| 2020 FY | 449.69 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 30.61 Million HKD | -1013.648% |
| CK Life Sciences Int'l., (Holdings) Inc. | 4.27 Billion HKD | 92.022% |